Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
1
Hanmi Pharmaceuticals announced a global licensing agreement for sonefpeglutide, a long-acting GLP-2 analog built on its proprietary LAPSCOVERY platform
This peptide helps increase your bodys own production of growth hormone, leading to better muscle growth, improved recovery, and even enhanced fat loss
This translated into a significantly higher likelihood of achieving the conventional glycemic target of HbA1c 30, those randomized to tirzepatide experienced 36 adjudicated cardiovascular deaths or heart failure worsening events versus 56 in the placebo group, representing a 38% reduction primarily driven by fewer heart failure exacerbations
US$ 28.07
US$ 29.38
US$ 27.08
US$ 25.20
US$ 21.56
US$ 28.53
